NanoViricides, Inc. Announces Symbol Change, Schedule for Filing
MIAMI, Jul 06, 2005 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets:NNVC), announced the change of its name from Edot-com.com, Inc. and stock symbol from ECMM to NNVC, effective July 5, 2005. "This change completes phase one of our entry into the public marketplace," stated Eugene Seymour, CEO of NanoViricides, "now our shareholders can identify our company by name."
"Shortly, we hope to have completed and filed a Form 10-SB, commencing our status as a fully-reporting company with the Securities and Exchange Commission," added Seymour. "We are working with our new auditors to complete all financial reports required for compliance in the hope that our securities may be quoted on the OTC Bulletin Board, and ultimately, listed on a national exchange. Our shareholders require the greater liquidity and market support that the bulletin board system affords buyers and sellers of our shares. We are excited at the milestones before us and proud of our achievements to date."
NanoViricides, Inc. ..NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. NanoViricides, Inc. has exclusive license in perpetuity for technologies developed by Theracour Pharma for the five virus types HIV, HCV, Herpes, Asian (bird) flu and Influenza. A NanoViricide(TM) is a nanoparticle that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus. When a NanoViricide(TM) drug particle enters the patient's blood stream, it attacks and immobilizes circulating virus particles. Once this is done, the active pharmaceutical ingredient is injected into the virus by the NanoViricide(TM) particle, destroying it. The company plans to develop novel NanoViricide(TM) drugs first against HIV, and anticipates that in 2006, it will license the products to major pharmaceutical companies.
SOURCE: NanoViricides, Inc.
NanoViricides, Inc., Miami
Leo Ehrlich, 718-339-2106
. |
